NCT00405457View on ClinicalTrials.gov

Efficacy and Safety of a New Multi-dose Lubricant Eye Drop Concomitant With Restasis® (Cyclosporine A) for the Treatment of Dry Eye Symptoms

PHASE4CompletedINTERVENTIONAL

Enrollment

50

Participants

Timeline

Start Date

November 30, 2006

Primary Completion Date

January 31, 2008

Study Completion Date

January 31, 2008

Conditions

Dry Eye

Interventions

DRUG

Restasis, Optive Tears

Restasis and Optive Tears use twice daily more frequently if needed

Trial Locations (1)

55404

Minnesota Eye Consultants, Minneapolis

Sponsors

Lead Sponsor

Innovative Medical

All Listed Sponsors

lead

Innovative Medical

INDUSTRY

NCT00405457 - Efficacy and Safety of a New Multi-dose Lubricant Eye Drop Concomitant With Restasis® (Cyclosporine A) for the Treatment of Dry Eye Symptoms | Biotech Hunter | Biotech Hunter